federal_register: 2024-30334
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-30334 | Statement of Organization, Functions, and Delegations of Authority | Notice | The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research's (CDER), Office of Surveillance and Epidemiology (OSE) and Office of New Drugs (OND) has modified their organizational structure. The new organizational structure was approved by the Secretary of Health and Human Services on November 20, 2014. | 2024-12-26 | 2024 | 12 | https://www.federalregister.gov/documents/2024/12/26/2024-30334/statement-of-organization-functions-and-delegations-of-authority | https://www.govinfo.gov/content/pkg/FR-2024-12-26/pdf/2024-30334.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research's (CDER), Office of Surveillance and Epidemiology (OSE) and Office of New Drugs (OND) has modified their organizational structure. The new organizational structure was... |